Late-Onset Alzheimer Disease

被引：37
|
作者：
Pierce, Aimee L. [1 ,2 ]
Bullain, Szofia S. [3 ,4 ]
Kawas, Claudia H. [5 ,6 ,7 ,8 ]
机构：
[1] Univ Calif Irvine, Dept Neurol, 1100 Med Plaza Dr, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1100 Med Plaza Dr, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Dept Neurol, 1515 Hewitt Hall, Irvine, CA 92697 USA
[4] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1515 Hewitt Hall, Irvine, CA 92697 USA
[5] Univ Calif Irvine, Dept Neurol, 1121 Gillespie, Irvine, CA 92697 USA
[6] Univ Calif Irvine, Dept Neurobiol & Behav, 1121 Gillespie, Irvine, CA 92697 USA
[7] Univ Calif Irvine, Dept Epidemiol, 1121 Gillespie, Irvine, CA 92697 USA
[8] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1121 Gillespie, Irvine, CA 92697 USA
来源：
NEUROLOGIC CLINICS | 2017年 / 35卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Late-onset; Alzheimer disease; Dementia; Oldest-old; Pathology; OLDEST-OLD; DEMENTIA; ASSOCIATION; AGE; PREDICTORS; EFFICACY; COMMON; RISK;
D O I：
10.1016/j.ncl.2017.01.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The oldest-old represent the fastest growing segment of society, and the risk of developing dementia continues to increase with advancing age into the 9th and 10th decades of life. The most common form of dementia in the oldest-old is Alzheimer disease (AD), although there are often mixed pathologies contributing to dementia in addition to amyloid plaques and neurofibrillary tangles. Diagnosing AD in the oldest-old is challenging due to cognitive and physical changes associated with aging. Treatment remains supportive, with current approved medications able to provide modest symptomatic benefit but unable to slow the progression of disease.
引用
收藏
页码：283 / +
页数：13
相关论文
共 50 条
  • [31] A2M is associated with late-onset Alzheimer disease
    Carina Dennis
    Nature Medicine, 1998, 4 : 888 - 888
  • [32] Early and late-onset Alzheimer's disease: What are the differences?
    Awada, Adnan A.
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2015, 6 (03) : 455 - +
  • [33] Neuropathologic heterogeneity in autosomal dominant and late-onset Alzheimer disease
    Cairns, Nigel J.
    BRAIN PATHOLOGY, 2019, 29 : 57 - 58
  • [34] Assessment of the genetic variance of late-onset Alzheimer's disease
    Ridge, Perry G.
    Hoyt, Kaitlyn B.
    Boehme, Kevin
    Mukherjee, Shubhabrata
    Crane, Paul K.
    Haines, Jonathan L.
    Mayeux, Richard
    Farrer, Lindsay A.
    Pericak-Vance, Margaret A.
    Schellenberg, Gerard D.
    Kauwe, John S. K.
    NEUROBIOLOGY OF AGING, 2016, 41
  • [35] Late-onset Alzheimer's disease associated to NEPRILYSIN gene
    Clarimón, J
    Bertranpetit, J
    Boada, M
    Tarraga, L
    Comas, D
    NEUROLOGY, 2002, 58 (07) : A41 - A41
  • [36] Studies in a large family with late-onset Alzheimer disease (LOAD)
    Martin, ES
    Martin, SE
    Edelsohn, L
    Borgaonkar, DS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 (03): : 163 - 170
  • [37] Genetic discoveries and advances in late-onset Alzheimer's disease
    Rezazadeh, Maryam
    Hosseinzadeh, Hassan
    Moradi, Mohsen
    Esfahani, Behnaz Salek
    Talebian, Shahrzad
    Parvin, Shaho
    Gharesouran, Jalal
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 16873 - 16884
  • [38] Innate Immunity and the Etiology of Late-Onset Alzheimer's Disease
    Eikelenboom, Piet
    van Exel, Erik
    Veerhuis, Rob
    Rozemuller, Annemieke J. M.
    van Gool, Willem A.
    Hoozemans, Jeroen J. M.
    NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 271 - 273
  • [39] Central Obesity in the Elderly is Related to Late-onset Alzheimer Disease
    Luchsinger, Jose A.
    Cheng, Derek
    Tang, Ming Xin
    Schupf, Nicole
    Mayeux, Richard
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2012, 26 (02): : 101 - 105
  • [40] Early- and late-onset Alzheimer disease: Are they the same entity?
    Tellechea, P.
    Pujol, N.
    Esteve-Belloch, P.
    Echeveste, B.
    Garcia-Eulate, M. R.
    Arbizu, J.
    Riverol, M.
    NEUROLOGIA, 2018, 33 (04): : 244 - 253
12345